Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-25-000805

Chief Financial Officer sold 45,167 shares at an average $19.77 ($893,095)

  • Chief Financial Officer acquired 100,000 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Myszkowski Kenneth Allen · Chief Financial Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2025-01-04 Grant or award : show line 1 in the form 10b5-1 +100,000 500,600 D
2025-01-06 Sale : show line 2 in the form 10b5-1 −17,765 $19.68 $349,615 482,835 D
2025-01-06 Sale : show line 3 in the form 10b5-1 −9,402 $20.10 $188,980 473,433 D
2025-01-07 Sale : show line 4 in the form 10b5-1 −8,000 $19.70 $157,600 465,433 D
2025-01-07 Sale : show line 5 in the form 10b5-1 −10,000 $19.69 $196,900 455,433 D
Open-market sales · 45,167 sh · avg $19.77 · $893,095
Loading xslF345X05/wk-form4_1736303271.xml…